Veiga-da-Cunha M et al. provided evidence that inhibitors of the kidney glucose transporter SGLT2 could reduce the level of 1,5AG6P to restore neutropenia in patients with G6PT and G6PC3 deficiency [12, 13]. This evidence concerns the gene SLC5A2 and neutropenia.